Prolonged Bleeding: When to See a Doctor

What "Prolonged Bleeding" Actually Means

Prolonged bleeding is bleeding that continues beyond the expected duration for its source site or physiological context. A healthy person's bleeding time from a small skin wound is roughly 1 to 9 minutes, measured by the Ivy method [1]. Menstrual bleeding lasting more than 7 days, or producing more than 80 mL of blood per cycle, meets the clinical definition of heavy menstrual bleeding (HMB) per the American College of Obstetricians and Gynecologists (ACOG) [2].

Duration alone does not define clinical concern. Volume, location, and associated symptoms all factor into urgency.

Bleeding Time vs. Clotting Time

Bleeding time tests primary hemostasis: platelet plug formation and vascular response. Clotting time tests secondary hemostasis: the coagulation cascade that converts fibrinogen to fibrin. Prolonged bleeding may reflect a problem in either system, or both. The prothrombin time (PT) and activated partial thromboplastin time (aPTT) are the standard screening tools for secondary hemostasis defects [3].

Menstrual vs. Non-Menstrual Prolonged Bleeding

Menstrual prolonged bleeding is the most common presentation in people with uteruses aged 12 to 51. Non-menstrual prolonged bleeding includes prolonged wound healing, excessive bruising, bleeding from gums or nose lasting more than 10 minutes, and bleeding after procedures. Both categories share some etiologies, particularly inherited coagulation disorders and anticoagulant medications.

Common Causes of Prolonged Bleeding

Prolonged bleeding arises from four broad categories: structural or anatomical abnormalities, hormonal dysregulation, coagulation disorders, and medications. The FIGO (International Federation of Gynecology and Obstetrics) PALM-COEIN classification system organizes uterine bleeding causes into structural (polyp, adenomyosis, leiomyoma, malignancy) and non-structural (coagulopathy, ovulatory dysfunction, endometrial, iatrogenic, not yet classified) groups [4].

Structural Causes

Uterine fibroids affect approximately 70% of White women and up to 80% of Black women by age 50 [5]. Submucosal fibroids distort the endometrial cavity and impair normal uterine contractility during menstruation, a mechanical reason bleeding continues beyond normal duration. Endometrial polyps and adenomyosis produce a similar pattern. Cervical and endometrial malignancies must be excluded, particularly in postmenopausal bleeding, which warrants evaluation within two weeks of presentation per National Institute for Health and Care Excellence (NICE) guidance [6].

Hormonal and Ovulatory Causes

Anovulatory cycles produce unopposed estrogen, which stimulates continuous endometrial proliferation without the stabilizing progesterone withdrawal that normally limits bleeding duration [7]. This pattern is most common at the extremes of reproductive life, within the first 2 to 3 years after menarche and during the perimenopause transition. Thyroid dysfunction compounds this: both hypothyroidism and hyperthyroidism disrupt the hypothalamic-pituitary-gonadal axis and alter platelet aggregation [8].

Inherited Coagulation Disorders

Von Willebrand disease (VWD) is the most common inherited bleeding disorder worldwide, with a prevalence of approximately 1% in the general population [9]. Women with VWD report heavy menstrual bleeding as their primary complaint in up to 74% of cases [10]. Hemophilia A (factor VIII deficiency) and hemophilia B (factor IX deficiency) are X-linked and predominantly affect males, but female carriers may bleed excessively. Platelet function disorders such as Glanzmann thrombasthenia and Bernard-Soulier syndrome are rarer but produce a similar phenotype of prolonged mucosal bleeding [11].

Medications and Anticoagulants

Anticoagulants are a leading iatrogenic cause. Warfarin prolongs the PT by inhibiting vitamin K-dependent clotting factors (II, VII, IX, X). Direct oral anticoagulants (DOACs) including rivaroxaban, apixaban, dabigatran, and edoxaban produce less predictable but clinically significant bleeding prolongation [12]. Antiplatelet agents (aspirin, clopidogrel) impair primary hemostasis. Selective serotonin reuptake inhibitors (SSRIs) deplete platelet serotonin stores and modestly increase bleeding time. A 2021 systematic review in the BMJ found that SSRI use was associated with a 1.7-fold increased risk of abnormal uterine bleeding [13].

When to Seek Emergency Care

Go to an emergency department immediately if any of the following apply. Soaking more than one pad or tampon per hour for two or more consecutive hours is the threshold used in clinical triage guidelines and by the American Academy of Family Physicians [14]. Passing blood clots larger than a quarter (approximately 2.5 cm diameter) suggests blood loss exceeding 80 mL per episode. Lightheadedness, syncope, rapid heart rate above 100 bpm, or a systolic blood pressure below 90 mmHg indicates hemodynamic compromise.

Signs of Serious Blood Loss

A hemoglobin drop to below 8 g/dL from acute blood loss commonly produces symptomatic anemia: fatigue severe enough to limit daily activity, pallor of the conjunctiva, and shortness of breath at rest. Postoperative bleeding from a wound that does not respond to 15 minutes of direct pressure also requires emergency evaluation, as does any bleeding following trauma to the head, neck, or torso.

Postmenopausal Bleeding: Always Evaluate

Any vaginal bleeding occurring 12 or more months after the final menstrual period is postmenopausal bleeding (PMB) until proven otherwise. The risk of endometrial carcinoma in women presenting with PMB ranges from 5% to 10% in primary care settings [15]. ACOG Practice Bulletin No. 149 states: "Postmenopausal bleeding should be evaluated promptly, as endometrial cancer is diagnosed in approximately 9% of women presenting with this symptom." Transvaginal ultrasound with endometrial thickness measurement is the recommended first step [16].

How Prolonged Bleeding Is Diagnosed

Diagnosis starts with a structured history and physical, then targeted laboratory and imaging tests. The history should capture bleeding duration per episode, total cycle length, clot size and frequency, personal and family history of bleeding, and a complete medication list including supplements (fish oil, vitamin E, and ginkgo biloba all prolong bleeding time).

Laboratory Workup

The standard first-line panel includes:

• Complete blood count (CBC) with differential and platelet count
• Prothrombin time (PT) and international normalized ratio (INR)
• Activated partial thromboplastin time (aPTT)
• Fibrinogen level
• Von Willebrand factor antigen (VWF:Ag) and activity (VWF:RCo or VWF:GPIbM)
• Factor VIII activity if VWD screening is positive

A 2020 ACOG Committee Opinion recommends screening all adolescents and women presenting with HMB for underlying bleeding disorders, citing evidence that up to 20% harbor an undiagnosed coagulopathy [17]. Thyroid-stimulating hormone (TSH) should be added when thyroid dysfunction is clinically suspected.

Imaging

Transvaginal ultrasound is the preferred first-line imaging modality for uterine causes. Saline-infusion sonohysterography improves sensitivity for intracavitary lesions such as polyps and submucosal fibroids from approximately 60% to 90% compared with standard ultrasound alone [18]. MRI pelvis is reserved for cases where ultrasound findings are equivocal or when the extent of adenomyosis or fibroid burden needs surgical mapping.

Endometrial Sampling

Endometrial biopsy is indicated for women aged 45 and older with HMB, and for younger women with risk factors including obesity (BMI over 35), chronic anovulation, or a history of tamoxifen use [19]. Office endometrial biopsy has a sensitivity of 81% to 99% for endometrial carcinoma when adequate tissue is obtained [20].

Treatment Options for Prolonged Bleeding

Treatment depends entirely on the underlying cause, bleeding severity, desire for future fertility, and patient preference. No single protocol fits all presentations.

Hormonal Therapies

The levonorgestrel-releasing intrauterine system (LNG-IUS, brand name Mirena, 52 mg) reduces menstrual blood loss by approximately 86% at 3 months and 97% at 12 months in randomized trials [21]. It is the most effective non-surgical medical option for HMB in women with a normal uterine cavity.

Combined oral contraceptives (COCs) reduce menstrual blood loss by 35% to 69% and are appropriate first-line treatment in women without contraindications to estrogen [22]. Progestin-only pills and depot medroxyprogesterone acetate provide alternatives for women with venous thromboembolism history.

Tranexamic acid, an antifibrinolytic agent, is taken at 1,300 mg three times daily for up to 5 days per menstrual cycle. The ECLIPSE trial (N=196) showed tranexamic acid reduced HMB by 40.4% vs. 8.9% for mefenamic acid over 3 treatment cycles [23].

Treatments for Structural Causes

Hysteroscopic polypectomy resolves bleeding in 75% to 100% of cases caused by endometrial polyps [24]. Uterine fibroid embolization achieves a 40% to 70% reduction in uterine volume and significant HMB improvement at 12 months in 85% of patients [25]. Endometrial ablation, which destroys the endometrial lining, reduces or eliminates HMB in 80% to 90% of appropriately selected patients but is contraindicated if future pregnancy is desired [26].

Treating Coagulopathies

Von Willebrand disease type 1 responds to desmopressin (DDAVP) 0.3 mcg/kg IV or intranasal desmopressin 300 mcg (Stimate), which triggers endothelial release of stored VWF and raises VWF:Ag levels two- to fivefold within 30 to 60 minutes [27]. Types 2 and 3 VWD require VWF concentrate replacement. The National Hemophilia Foundation guidelines recommend a multidisciplinary approach involving hematology, gynecology, and primary care for women with inherited bleeding disorders and HMB [28].

Reversing Anticoagulant Effects

Warfarin over-anticoagulation with active bleeding is managed with vitamin K (phytonadione) 2.5 to 10 mg orally or IV, plus 4-factor prothrombin complex concentrate (4F-PCC) for life-threatening bleeding [29]. Andexanet alfa (Andexxa) reverses factor Xa inhibitors (rivaroxaban, apixaban), with the FDA approving its use specifically for life-threatening or uncontrolled bleeding [30]. Idarucizumab (Praxbind) reverses dabigatran.

Prolonged Wound Bleeding: A Separate Clinical Picture

Post-procedural or post-traumatic bleeding lasting beyond 15 minutes of direct pressure, or recurring within 24 hours of apparent cessation, warrants laboratory evaluation regardless of the patient's baseline history. A proportion of patients who bleed after dental extractions or minor surgery harbor undiagnosed platelet function disorders detectable only by platelet aggregation studies or PFA-100 closure time testing [31].

The HealthRX clinical team uses a three-tier triage framework for prolonged bleeding presentations:

Tier 1 (Emergency, same day): Hemodynamic instability, soaking 1+ pad/hour for 2+ hours, postoperative active bleeding, or suspected trauma-related vascular injury.

Tier 2 (Urgent, within 72 hours): Postmenopausal bleeding of any amount, new HMB with hemoglobin below 10 g/dL, or any bleeding in a patient on anticoagulants that exceeds their usual pattern.

Tier 3 (Routine, within 2 weeks): New-onset HMB with stable hemoglobin, menstrual cycles extending beyond 7 days for more than 3 consecutive cycles, or family history of bleeding disorder with personal symptoms.

This framework is designed to match clinical urgency to resource allocation without under-triaging the most common serious missed diagnosis: undiagnosed VWD in adolescent girls presenting with heavy periods since menarche.

Special Populations

Adolescents

HMB at menarche carries a significantly higher prevalence of underlying coagulopathy than HMB presenting in adult women. A study published in the Journal of Pediatric and Adolescent Gynecology found that 19% of adolescents hospitalized for menorrhagia had an identifiable bleeding disorder, most commonly VWD [32]. The American Society of Pediatric Hematology/Oncology recommends VWD screening for all adolescents hospitalized with HMB.

Perimenopause

Anovulatory cycles become more frequent in the 2 to 10 years before the final menstrual period, producing erratic and sometimes prolonged bleeding. A mean of 4.7 years of menstrual irregularity precedes the final menstrual period per the SWAN (Study of Women's Health Across the Nation) longitudinal cohort [33]. Endometrial sampling is indicated in perimenopausal women with unscheduled bleeding who have risk factors for endometrial hyperplasia.

Pregnancy-Related Bleeding

Bleeding in the first trimester affects 20% to 25% of pregnancies and may indicate threatened miscarriage, ectopic pregnancy, or subchorionic hemorrhage [34]. Any first-trimester bleeding lasting more than 3 days or accompanied by pain requires urgent evaluation including serum beta-hCG measurement and transvaginal ultrasound. Postpartum hemorrhage, defined as blood loss exceeding 1,000 mL within 24 hours of delivery, is a leading cause of maternal mortality worldwide and demands immediate obstetric intervention [35].

Patients on Anticoagulation Therapy

People taking DOACs or warfarin experience a baseline increase in bleeding duration from even minor injuries. Patients should establish a personal baseline with their prescribing clinician, document typical wound-healing duration, and seek medical attention for any bleeding that deviates from that individual baseline or that does not stop within 30 minutes of direct pressure.

Lifestyle Factors and Nutritional Contributions

Vitamin K deficiency prolongs the PT by impairing synthesis of clotting factors II, VII, IX, and X. Populations at risk include people on long-term broad-spectrum antibiotics, those with inflammatory bowel disease, and newborns without prophylactic vitamin K injection [36]. Iron deficiency, while not itself a cause of prolonged bleeding, is the direct result of chronic blood loss and creates a cycle where fatigue limits care-seeking. Serum ferritin below 30 ng/mL is consistent with depleted iron stores even when hemoglobin remains normal [37].

Alcohol consumption above 14 units per week impairs platelet aggregation and can moderately prolong bleeding time by inhibiting thromboxane A2 production, a finding documented in a dose-response analysis published in the American Journal of Hematology [38].